Skip to main content

Measles Virus Vaccine / Mumps Virus Vaccine / Rubella Virus Vaccine News (Page 2)

COVID Vaccine Hesitancy Reducing Childhood Vaccinations

FRIDAY, Jan. 24, 2025 – Hesitancy over the COVID-19 vaccine is leading some parents to skip important vaccinations for their children. Young children of parents who declined the COVID vaccine are...

Global Coverage With Measles Vaccine Declined During COVID-19

MONDAY, Nov. 18, 2024 – Global coverage with measles vaccination declined during the COVID-19 pandemic, and estimated measles cases increased 20 percent worldwide from 2022 to 2023, according to...

Falling Vaccination Rates Brings Spikes in Measles Worldwide

FRIDAY, Nov. 15, 2024 – Waning vaccine coverage has fueled a 20% spike in measles cases worldwide, with 10.3 million people struck by the preventable illness in 2023, health officials reported...

Measles Cases in England Consistent With Waning of Vaccine Immunity

MONDAY, Sept. 30, 2024 – Measles cases in England are consistent with the waning of vaccine-induced immunity, according to a study published online Sept. 26 in The Lancet Public Health. Alexis...

FDA Approves Priorix (Measles, Mumps and Rubella Vaccine, Live) for the Prevention of Measles, Mumps and Rubella in Individuals 12 Months of Age and Older

Priorix becomes an additional source of measles, mumps and rubella vaccine for US patients London UK 06 June 2022 – GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Measles Virus Vaccine / Mumps Virus Vaccine / Rubella Virus Vaccine patient information at Drugs.com